25 XP   0   0   10

Alzinova AB
Buy, Hold or Sell?

Let's analyse Alzinova together

PenkeI guess you are interested in Alzinova AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Alzinova AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Alzinova AB

I send you an email if I find something interesting about Alzinova AB.

Quick analysis of Alzinova (30 sec.)










What can you expect buying and holding a share of Alzinova? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr2.56
Expected worth in 1 year
kr2.74
How sure are you?
24.0%

+ What do you gain per year?

Total Gains per Share
kr0.19
Return On Investment
11.0%

For what price can you sell your share?

Current Price per Share
kr1.70
Expected price per share
kr0.98 - kr2
How sure are you?
50%

1. Valuation of Alzinova (5 min.)




Live pricePrice per Share (EOD)

kr1.70

Intrinsic Value Per Share

kr-12.81 - kr-15.14

Total Value Per Share

kr-10.25 - kr-12.58

2. Growth of Alzinova (5 min.)




Is Alzinova growing?

Current yearPrevious yearGrowGrow %
How rich?$10.4m$9.5m$874.2k8.3%

How much money is Alzinova making?

Current yearPrevious yearGrowGrow %
Making money-$378.6k-$300.2k-$78.3k-20.7%
Net Profit Margin-504.1%-34.7%--

How much money comes from the company's main activities?

3. Financial Health of Alzinova (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#670 / 1010

Most Revenue
#571 / 1010

Most Profit
#195 / 1010

Most Efficient
#738 / 1010

What can you expect buying and holding a share of Alzinova? (5 min.)

Welcome investor! Alzinova's management wants to use your money to grow the business. In return you get a share of Alzinova.

What can you expect buying and holding a share of Alzinova?

First you should know what it really means to hold a share of Alzinova. And how you can make/lose money.

Speculation

The Price per Share of Alzinova is kr1.7. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alzinova.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alzinova, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr2.56. Based on the TTM, the Book Value Change Per Share is kr0.05 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alzinova.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-0.6%-0.01-0.5%-0.01-0.4%-0.01-0.3%0.00-0.3%
Usd Book Value Change Per Share-0.01-0.6%0.000.3%0.010.5%0.010.3%0.010.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.6%0.000.3%0.010.5%0.010.3%0.010.6%
Usd Price Per Share0.28-0.28-0.27-0.67-0.53-
Price to Earnings Ratio-7.14--8.25--11.48--53.03--42.43-
Price-to-Total Gains Ratio-28.57--22.68-139.83--1,463.29--1,463.29-
Price to Book Ratio1.19-1.19-1.33-4.51-3.61-
Price-to-Total Gains Ratio-28.57--22.68-139.83--1,463.29--1,463.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.15623
Number of shares6400
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.000.01
Gains per Quarter (6400 shares)27.4933.09
Gains per Year (6400 shares)109.95132.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101101000132122
202202100265254
303303200397386
404404300529518
505505400662650
606606500794782
707707600926914
80880870010591046
90990980011911178
10011001090013241310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.025.00.00.0%0.025.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%6.019.00.024.0%6.019.00.024.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.025.00.0%0.00.025.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%6.019.00.024.0%6.019.00.024.0%

Fundamentals of Alzinova

About Alzinova AB

Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that neutralizes the toxic oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.

Fundamental data was last updated by Penke on 2024-04-19 04:58:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Alzinova AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Alzinova earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • A Net Profit Margin of -1,752.2% means that kr-17.52 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alzinova AB:

  • The MRQ is -1,752.2%. The company is making a huge loss. -2
  • The TTM is -504.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,752.2%TTM-504.1%-1,248.1%
TTM-504.1%YOY-34.7%-469.5%
TTM-504.1%5Y-107.8%-396.4%
5Y-107.8%10Y-86.2%-21.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,752.2%-207.2%-1,545.0%
TTM-504.1%-216.8%-287.3%
YOY-34.7%-282.3%+247.6%
5Y-107.8%-436.8%+329.0%
10Y-86.2%-597.3%+511.1%
1.1.2. Return on Assets

Shows how efficient Alzinova is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • -3.8% Return on Assets means that Alzinova generated kr-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alzinova AB:

  • The MRQ is -3.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-3.4%-0.4%
TTM-3.4%YOY-3.0%-0.5%
TTM-3.4%5Y-2.6%-0.8%
5Y-2.6%10Y-2.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%-13.3%+9.5%
TTM-3.4%-12.8%+9.4%
YOY-3.0%-11.6%+8.6%
5Y-2.6%-13.8%+11.2%
10Y-2.6%-15.6%+13.0%
1.1.3. Return on Equity

Shows how efficient Alzinova is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • -4.2% Return on Equity means Alzinova generated kr-0.04 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alzinova AB:

  • The MRQ is -4.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.2%TTM-3.6%-0.5%
TTM-3.6%YOY-3.1%-0.5%
TTM-3.6%5Y-2.8%-0.9%
5Y-2.8%10Y-2.8%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.2%-16.9%+12.7%
TTM-3.6%-16.1%+12.5%
YOY-3.1%-14.9%+11.8%
5Y-2.8%-19.3%+16.5%
10Y-2.8%-20.1%+17.3%

1.2. Operating Efficiency of Alzinova AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alzinova is operating .

  • Measures how much profit Alzinova makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alzinova AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-92.6%+92.6%
TTM-92.6%YOY-34.9%-57.7%
TTM-92.6%5Y-25.5%-67.1%
5Y-25.5%10Y-20.4%-5.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM-92.6%-238.5%+145.9%
YOY-34.9%-288.4%+253.5%
5Y-25.5%-486.2%+460.7%
10Y-20.4%-628.4%+608.0%
1.2.2. Operating Ratio

Measures how efficient Alzinova is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 18.83 means that the operating costs are kr18.83 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Alzinova AB:

  • The MRQ is 18.826. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.365. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ18.826TTM5.365+13.461
TTM5.365YOY0.349+5.016
TTM5.3655Y1.143+4.222
5Y1.14310Y0.914+0.229
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ18.8263.235+15.591
TTM5.3653.310+2.055
YOY0.3493.838-3.489
5Y1.1435.679-4.536
10Y0.9147.823-6.909

1.3. Liquidity of Alzinova AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alzinova is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.97 means the company has kr2.97 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Alzinova AB:

  • The MRQ is 2.966. The company is able to pay all its short-term debts. +1
  • The TTM is 5.658. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.966TTM5.658-2.692
TTM5.658YOY8.591-2.933
TTM5.6585Y10.224-4.566
5Y10.22410Y10.494-0.269
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9663.863-0.897
TTM5.6584.169+1.489
YOY8.5915.337+3.254
5Y10.2246.122+4.102
10Y10.4946.434+4.060
1.3.2. Quick Ratio

Measures if Alzinova is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • A Quick Ratio of 2.97 means the company can pay off kr2.97 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alzinova AB:

  • The MRQ is 2.966. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.658. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.966TTM5.658-2.692
TTM5.658YOY8.487-2.829
TTM5.6585Y10.131-4.473
5Y10.13110Y10.355-0.224
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9663.504-0.538
TTM5.6583.991+1.667
YOY8.4875.371+3.116
5Y10.1316.088+4.043
10Y10.3556.395+3.960

1.4. Solvency of Alzinova AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alzinova assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alzinova to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Alzinova assets are financed with 7.6% credit (debt) and the remaining percentage (100% - 7.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alzinova AB:

  • The MRQ is 0.076. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.057. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.076TTM0.057+0.019
TTM0.057YOY0.054+0.003
TTM0.0575Y0.055+0.002
5Y0.05510Y0.060-0.005
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0760.339-0.263
TTM0.0570.337-0.280
YOY0.0540.271-0.217
5Y0.0550.368-0.313
10Y0.0600.388-0.328
1.4.2. Debt to Equity Ratio

Measures if Alzinova is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alzinova to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.2% means that company has kr0.08 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alzinova AB:

  • The MRQ is 0.082. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.061. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.082TTM0.061+0.021
TTM0.061YOY0.057+0.003
TTM0.0615Y0.058+0.002
5Y0.05810Y0.065-0.006
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0820.392-0.310
TTM0.0610.403-0.342
YOY0.0570.335-0.278
5Y0.0580.427-0.369
10Y0.0650.461-0.396

2. Market Valuation of Alzinova AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Alzinova generates.

  • Above 15 is considered overpriced but always compare Alzinova to the Biotechnology industry mean.
  • A PE ratio of -7.14 means the investor is paying kr-7.14 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alzinova AB:

  • The EOD is -4.000. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.142. Based on the earnings, the company is expensive. -2
  • The TTM is -8.254. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.000MRQ-7.142+3.141
MRQ-7.142TTM-8.254+1.113
TTM-8.254YOY-11.479+3.225
TTM-8.2545Y-53.033+44.779
5Y-53.03310Y-42.426-10.607
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.000-2.300-1.700
MRQ-7.142-2.656-4.486
TTM-8.254-2.718-5.536
YOY-11.479-4.145-7.334
5Y-53.033-6.258-46.775
10Y-42.426-6.315-36.111
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alzinova AB:

  • The EOD is -1.740. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.106. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.658. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.740MRQ-3.106+1.366
MRQ-3.106TTM-4.658+1.553
TTM-4.658YOY-5.630+0.972
TTM-4.6585Y-21.300+16.642
5Y-21.30010Y-17.040-4.260
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.740-2.974+1.234
MRQ-3.106-3.306+0.200
TTM-4.658-3.508-1.150
YOY-5.630-5.613-0.017
5Y-21.300-8.378-12.922
10Y-17.040-8.873-8.167
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Alzinova is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.19 means the investor is paying kr1.19 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Alzinova AB:

  • The EOD is 0.665. Based on the equity, the company is cheap. +2
  • The MRQ is 1.187. Based on the equity, the company is underpriced. +1
  • The TTM is 1.192. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.665MRQ1.187-0.522
MRQ1.187TTM1.192-0.005
TTM1.192YOY1.331-0.140
TTM1.1925Y4.509-3.317
5Y4.50910Y3.607+0.902
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.6651.914-1.249
MRQ1.1872.116-0.929
TTM1.1922.097-0.905
YOY1.3312.881-1.550
5Y4.5093.550+0.959
10Y3.6073.936-0.329
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Alzinova AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1060.047-327%0.096-211%0.056-289%0.102-204%
Book Value Per Share--2.5572.5590%2.346+9%1.966+30%1.732+48%
Current Ratio--2.9665.658-48%8.591-65%10.224-71%10.494-72%
Debt To Asset Ratio--0.0760.057+33%0.054+40%0.055+38%0.060+26%
Debt To Equity Ratio--0.0820.061+35%0.057+43%0.058+41%0.065+27%
Dividend Per Share----0%-0%-0%-0%
Eps---0.106-0.093-13%-0.073-31%-0.056-47%-0.049-54%
Free Cash Flow Per Share---0.244-0.195-20%-0.151-38%-0.136-44%-0.124-49%
Free Cash Flow To Equity Per Share---0.244-0.056-77%0.187-230%0.069-456%0.074-431%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---15.136--------
Intrinsic Value_10Y_min---12.805--------
Intrinsic Value_1Y_max---0.790--------
Intrinsic Value_1Y_min---0.775--------
Intrinsic Value_3Y_max---2.927--------
Intrinsic Value_3Y_min---2.783--------
Intrinsic Value_5Y_max---5.732--------
Intrinsic Value_5Y_min---5.273--------
Market Cap75703210.000-79%135152495.500134874174.875+0%132536281.625+2%322517940.250-58%258014352.200-48%
Net Profit Margin---17.522-5.041-71%-0.347-98%-1.078-94%-0.862-95%
Operating Margin----0.9260%-0.3490%-0.2550%-0.2040%
Operating Ratio--18.8265.365+251%0.349+5297%1.143+1547%0.914+1959%
Pb Ratio0.665-79%1.1871.1920%1.331-11%4.509-74%3.607-67%
Pe Ratio-4.000+44%-7.142-8.254+16%-11.479+61%-53.033+643%-42.426+494%
Price Per Share1.700-79%3.0353.029+0%2.976+2%7.243-58%5.794-48%
Price To Free Cash Flow Ratio-1.740+44%-3.106-4.658+50%-5.630+81%-21.300+586%-17.040+449%
Price To Total Gains Ratio-16.002+44%-28.567-22.681-21%139.833-120%-1463.289+5022%-1463.289+5022%
Quick Ratio--2.9665.658-48%8.487-65%10.131-71%10.355-71%
Return On Assets---0.038-0.034-11%-0.030-23%-0.026-32%-0.026-32%
Return On Equity---0.042-0.036-12%-0.031-25%-0.028-33%-0.028-33%
Total Gains Per Share---0.1060.047-327%0.096-211%0.056-289%0.102-204%
Usd Book Value--10463550.20010473079.8850%9598814.370+9%8047226.772+30%7087735.970+48%
Usd Book Value Change Per Share---0.0100.004-327%0.009-211%0.005-289%0.009-204%
Usd Book Value Per Share--0.2350.2350%0.216+9%0.181+30%0.159+48%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.010-0.009-13%-0.007-31%-0.005-47%-0.005-54%
Usd Free Cash Flow---999780.100-799907.479-20%-619111.208-38%-555727.603-44%-506546.845-49%
Usd Free Cash Flow Per Share---0.022-0.018-20%-0.014-38%-0.012-44%-0.011-49%
Usd Free Cash Flow To Equity Per Share---0.022-0.005-77%0.017-230%0.006-456%0.007-431%
Usd Market Cap6957124.999-79%12420514.33612394936.671+0%12180084.281+2%29639398.709-58%23711518.967-48%
Usd Price Per Share0.156-79%0.2790.278+0%0.274+2%0.666-58%0.532-48%
Usd Profit---434778.900-378613.273-13%-300281.963-31%-228788.584-47%-201896.022-54%
Usd Revenue--24813.000327634.597-92%78172.116-68%81161.343-69%64929.074-62%
Usd Total Gains Per Share---0.0100.004-327%0.009-211%0.005-289%0.009-204%
 EOD+3 -5MRQTTM+4 -28YOY+7 -255Y+6 -2610Y+6 -26

3.2. Fundamental Score

Let's check the fundamental score of Alzinova AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.000
Price to Book Ratio (EOD)Between0-10.665
Net Profit Margin (MRQ)Greater than0-17.522
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.966
Current Ratio (MRQ)Greater than12.966
Debt to Asset Ratio (MRQ)Less than10.076
Debt to Equity Ratio (MRQ)Less than10.082
Return on Equity (MRQ)Greater than0.15-0.042
Return on Assets (MRQ)Greater than0.05-0.038
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Alzinova AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.265
Ma 20Greater thanMa 501.803
Ma 50Greater thanMa 1001.933
Ma 100Greater thanMa 2002.388
OpenGreater thanClose1.748
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Gross Profit  6,8052,5399,3442,69212,037-5,4376,600-11,413-4,813
Cost of Revenue  -3,402-1,270-4,672-1,346-6,0182,718-3,3008,3835,083



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets123,189
Total Liabilities9,331
Total Stockholder Equity113,858
 As reported
Total Liabilities 9,331
Total Stockholder Equity+ 113,858
Total Assets = 123,189

Assets

Total Assets123,189
Total Current Assets25,304
Long-term Assets97,885
Total Current Assets
Cash And Cash Equivalents 22,026
Net Receivables 3,278
Total Current Assets  (as reported)25,304
Total Current Assets  (calculated)25,304
+/-0
Long-term Assets
Other Assets 0
Long-term Assets  (as reported)97,885
Long-term Assets  (calculated)0
+/- 97,885

Liabilities & Shareholders' Equity

Total Current Liabilities8,531
Long-term Liabilities800
Total Stockholder Equity113,858
Total Current Liabilities
Accounts payable 2,493
Other Current Liabilities 6,038
Total Current Liabilities  (as reported)8,531
Total Current Liabilities  (calculated)8,531
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)800
Long-term Liabilities  (calculated)0
+/- 800
Total Stockholder Equity
Common Stock11,712
Retained Earnings -158,308
Accumulated Other Comprehensive Income 94,190
Other Stockholders Equity 166,264
Total Stockholder Equity (as reported)113,858
Total Stockholder Equity (calculated)113,858
+/-0
Other
Cash and Short Term Investments 22,026
Common Stock Shares Outstanding 44,531
Liabilities and Stockholders Equity 123,189
Net Debt -21,226
Net Working Capital 16,773
Short Long Term Debt Total 800



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
0
0
0
31,721
30,867
30,795
31,317
66,088
65,589
65,498
64,335
63,531
62,465
60,993
58,507
100,816
101,014
98,630
94,115
91,691
97,169
117,212
114,959
111,621
107,066
126,738
126,328
123,189
123,189126,328126,738107,066111,621114,959117,21297,16991,69194,11598,630101,014100,81658,50760,99362,46563,53164,33565,49865,58966,08831,31730,79530,86731,721000
   > Total Current Assets 
0
0
0
18,602
14,329
11,224
9,056
43,557
40,982
39,507
37,082
34,109
26,937
23,323
17,552
56,490
49,728
42,072
35,191
30,044
28,598
45,574
40,080
33,340
24,113
37,767
34,057
25,304
25,30434,05737,76724,11333,34040,08045,57428,59830,04435,19142,07249,72856,49017,55223,32326,93734,10937,08239,50740,98243,5579,05611,22414,32918,602000
       Cash And Cash Equivalents 
0
0
0
17,882
14,180
11,013
8,600
42,354
40,649
39,127
36,718
33,734
26,338
21,844
16,267
55,977
49,426
41,109
34,341
28,836
26,777
44,060
38,877
32,038
22,687
36,580
32,905
22,026
22,02632,90536,58022,68732,03838,87744,06026,77728,83634,34141,10949,42655,97716,26721,84426,33833,73436,71839,12740,64942,3548,60011,01314,18017,882000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
277
265
416
732
258
441
176
699
683
705
651
968
833
1,303
1,425
1,187
1,152
3,278
3,2781,1521,1871,4251,3038339686517056836991764412587324162652770000000000
       Other Current Assets 
0
0
0
720
149
211
456
1,204
332
380
364
375
599
1,479
1,285
513
302
963
850
1,209
1,822
1,514
1,204
1,303
1,425
1,187
1,152
0
01,1521,1871,4251,3031,2041,5141,8221,2098509633025131,2851,4795993753643803321,204456211149720000
   > Long-term Assets 
0
0
0
13,119
16,538
19,571
22,261
22,530
24,607
25,990
27,253
29,422
35,529
37,670
40,955
44,326
51,285
56,558
58,924
61,647
68,570
71,638
74,878
78,281
82,953
88,971
92,271
97,885
97,88592,27188,97182,95378,28174,87871,63868,57061,64758,92456,55851,28544,32640,95537,67035,52929,42227,25325,99024,60722,53022,26119,57116,53813,119000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
1,768
1,686
1,848
1,913
1,944
1,820
1,713
1,567
0
0
0
0
0
0
0
0
0
0000000001,5671,7131,8201,9441,9131,8481,6861,76800000000000
       Intangible Assets 
0
0
0
13,119
16,538
19,571
22,261
22,530
24,607
25,990
27,253
29,422
35,529
37,670
40,955
44,326
51,285
56,558
58,924
61,647
68,570
71,638
74,878
78,281
82,953
88,971
92,271
0
092,27188,97182,95378,28174,87871,63868,57061,64758,92456,55851,28544,32640,95537,67035,52929,42227,25325,99024,60722,53022,26119,57116,53813,119000
       Other Assets 
0
0
0
0
0
0
0
0
0
24,405
25,642
27,795
33,897
36,038
39,093
42,693
49,653
54,926
57,292
60,015
66,938
70,006
73,246
76,649
0
0
0
0
000076,64973,24670,00666,93860,01557,29254,92649,65342,69339,09336,03833,89727,79525,64224,405000000000
> Total Liabilities 
0
0
0
2,329
2,331
3,000
3,982
2,335
3,006
2,935
2,380
4,420
5,130
4,500
3,255
4,792
6,451
6,247
3,188
3,220
8,323
4,065
4,691
6,088
5,804
4,600
7,739
9,331
9,3317,7394,6005,8046,0884,6914,0658,3233,2203,1886,2476,4514,7923,2554,5005,1304,4202,3802,9353,0062,3353,9823,0002,3312,329000
   > Total Current Liabilities 
0
0
0
1,529
1,531
2,200
3,182
1,535
2,206
2,135
1,580
3,620
4,330
3,700
2,455
3,992
5,651
5,447
2,388
2,420
7,523
3,265
3,891
5,288
5,004
3,800
6,939
8,531
8,5316,9393,8005,0045,2883,8913,2657,5232,4202,3885,4475,6513,9922,4553,7004,3303,6201,5802,1352,2061,5353,1822,2001,5311,529000
       Accounts payable 
0
0
0
368
257
801
675
48
947
716
174
425
1,331
2,307
964
1,912
4,146
3,707
1,016
792
5,878
1,434
1,990
3,170
2,165
1,925
2,015
2,493
2,4932,0151,9252,1653,1701,9901,4345,8787921,0163,7074,1461,9129642,3071,33142517471694748675801257368000
       Other Current Liabilities 
0
0
0
1,161
1,274
1,399
2,507
1,487
1,259
1,419
1,405
3,195
2,998
1,394
1,491
2,080
1,506
1,740
1,372
1,627
1,645
1,831
1,901
2,117
2,839
1,875
4,924
6,038
6,0384,9241,8752,8392,1171,9011,8311,6451,6271,3721,7401,5062,0801,4911,3942,9983,1951,4051,4191,2591,4872,5071,3991,2741,161000
   > Long-term Liabilities 
0
0
0
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800
800800800800800800800800800800800800800800800800800800800800800800800800800000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
800
800
800
800
800
0
08008008008008000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000008000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
24,405
25,642
27,795
33,897
36,038
39,093
42,693
49,653
54,926
57,292
60,015
66,938
70,006
73,246
76,649
0
0
0
0
000076,64973,24670,00666,93860,01557,29254,92649,65342,69339,09336,03833,89727,79525,64224,405000000000
> Total Stockholder Equity
0
0
0
29,392
28,536
27,795
27,335
63,753
62,582
62,563
61,955
59,111
57,336
56,493
55,252
96,024
94,563
92,383
90,927
88,472
88,846
113,147
110,268
105,533
101,262
122,138
118,589
113,858
113,858118,589122,138101,262105,533110,268113,14788,84688,47290,92792,38394,56396,02455,25256,49357,33659,11161,95562,56362,58263,75327,33527,79528,53629,392000
   Common Stock
0
0
0
1,441
1,441
1,441
1,441
1,441
1,980
2,008
2,008
2,008
2,008
2,008
2,008
4,149
4,149
4,149
4,149
4,149
4,263
8,526
8,526
8,526
8,526
11,712
11,712
11,712
11,71211,71211,7128,5268,5268,5268,5264,2634,1494,1494,1494,1494,1492,0082,0082,0082,0082,0082,0081,9801,4411,4411,4411,4411,441000
   Retained Earnings Total Equity0000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
74,586
79,258
85,276
88,576
94,190
94,19088,57685,27679,25874,58600000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
77,602
77,602
69,359
77,602
118,873
278,842
118,873
278,842
118,873
121,415
144,752
144,645
144,645
144,645
166,264
166,264
0
0166,264166,264144,645144,645144,645144,752121,415118,873278,842118,873278,842118,87377,60269,35977,60277,60200000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
0
0
0
47,786
51,182
54,080
56,739
95,538
98,783
99,938
101,175
103,328
109,162
103,328
114,441
159,497
166,457
171,730
174,096
176,819
186,284
212,690
215,822
144,645
144,645
166,264
166,264
166,264
166,264166,264166,264144,645144,645215,822212,690186,284176,819174,096171,730166,457159,497114,441103,328109,162103,328101,17599,93898,78395,53856,73954,08051,18247,786000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue270
Cost of Revenue-16,792
Gross Profit-16,522-16,522
 
Operating Income (+$)
Gross Profit-16,522
Operating Expense-0
Operating Income-16,522-16,522
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense00
 
Net Interest Income (+$)
Interest Income19
Interest Expense-98
Other Finance Cost-52
Net Interest Income-27
 
Pretax Income (+$)
Operating Income-16,522
Net Interest Income-27
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-16,480-16,564
EBIT - interestExpense = -98
-16,480
-16,382
Interest Expense98
Earnings Before Interest and Taxes (EBIT)0-16,382
Earnings Before Interest and Taxes (EBITDA)-16,522
 
After tax Income (+$)
Income Before Tax-16,480
Tax Provision-0
Net Income From Continuing Ops-16,484-16,480
Net Income-16,480
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,792
Total Other Income/Expenses Net4227
 

Technical Analysis of Alzinova
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alzinova. The general trend of Alzinova is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alzinova's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alzinova AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.966 < 2 < 2.

The bearish price targets are: 1.69 > 0.98.

Tweet this
Alzinova AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alzinova AB. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alzinova AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alzinova AB. The current macd is -0.05093747.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Alzinova price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Alzinova. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Alzinova price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Alzinova AB Daily Moving Average Convergence/Divergence (MACD) ChartAlzinova AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alzinova AB. The current adx is 15.78.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alzinova shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Alzinova AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alzinova AB. The current sar is 2.13606.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Alzinova AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alzinova AB. The current rsi is 39.26. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Alzinova AB Daily Relative Strength Index (RSI) ChartAlzinova AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alzinova AB. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alzinova price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alzinova AB Daily Stochastic Oscillator ChartAlzinova AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alzinova AB. The current cci is -151.99649929.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Alzinova AB Daily Commodity Channel Index (CCI) ChartAlzinova AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alzinova AB. The current cmo is -24.30295287.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Alzinova AB Daily Chande Momentum Oscillator (CMO) ChartAlzinova AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alzinova AB. The current willr is -92.90187891.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Alzinova AB Daily Williams %R ChartAlzinova AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alzinova AB.

Alzinova AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alzinova AB. The current atr is 0.14288299.

Alzinova AB Daily Average True Range (ATR) ChartAlzinova AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alzinova AB. The current obv is 1,433,851.

Alzinova AB Daily On-Balance Volume (OBV) ChartAlzinova AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alzinova AB. The current mfi is 57.05.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alzinova AB Daily Money Flow Index (MFI) ChartAlzinova AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alzinova AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Alzinova AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alzinova AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.265
Ma 20Greater thanMa 501.803
Ma 50Greater thanMa 1001.933
Ma 100Greater thanMa 2002.388
OpenGreater thanClose1.748
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Alzinova with someone you think should read this too:
  • Are you bullish or bearish on Alzinova? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alzinova? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alzinova AB

I send you an email if I find something interesting about Alzinova AB.


Comments

How you think about this?

Leave a comment

Stay informed about Alzinova AB.

Receive notifications about Alzinova AB in your mailbox!